Rifampin

Description

1. Product Overview

Rifampin is a high-value, broad-spectrum antibiotic belonging to the rifamycin class, widely utilized in pharmaceutical manufacturing for the treatment of serious bacterial infections, particularly tuberculosis and other mycobacterial diseases. As a critical active pharmaceutical ingredient (API), it plays a central role in global public health programs and combination drug therapies. Its strong bactericidal activity and proven clinical efficacy make it an indispensable component in anti-infective drug formulations. Rifampin’s strategic importance is underscored by its inclusion in essential medicines lists worldwide and its sustained demand across regulated and emerging markets. For industrial buyers, it represents a reliable, high-demand API with consistent global consumption patterns.

2. Key Specifications & Technical Characteristics

• Chemical Composition: Rifampicin (C₄₃H₅₈N₄O₁₂)
• Molecular Weight: 822.94 g/mol
• Purity Level: ≥ 98.0% (Pharmaceutical Grade, compliant with USP/EP/BP standards)
• Appearance: Reddish-orange to dark red crystalline powder
• Solubility: Slightly soluble in water; soluble in organic solvents such as methanol and chloroform
• Bulk Density: Typically 0.3–0.6 g/cm³ (varies by processing)
• Particle Size: Customizable based on formulation requirements (micronized grades available)
• Packaging Options:
  • 25 kg fiber drums with double polyethylene inner lining
  • Custom pharmaceutical-grade packaging available upon request
• Shelf Life: 24–36 months when stored in a cool, dry, light-protected environment

3. Core Industrial Applications

Rifampin is primarily used in the pharmaceutical and biopharmaceutical industries, particularly in the production of anti-tuberculosis and antibacterial drug formulations. It is a cornerstone API in fixed-dose combination therapies used in global TB eradication programs and hospital-grade antibiotics.

Key operational use cases include:

• Manufacturing of oral capsules, tablets, and injectable formulations
• Integration into multi-drug regimens for tuberculosis and leprosy treatment
• Use in research and development of advanced antimicrobial therapies

Rifampin outperforms many alternatives due to its high potency against Mycobacterium tuberculosis, rapid bactericidal action, and ability to penetrate tissues effectively. Its compatibility in combination therapies enhances treatment efficacy while reducing resistance risks, delivering both clinical and economic advantages for manufacturers.

4. Competitive Advantages

• Quality Consistency: Produced under stringent GMP conditions with batch-to-batch uniformity and full regulatory compliance
• Supply Reliability: Scalable production capacity ensuring uninterrupted supply for large-volume pharmaceutical manufacturing
• Logistics Capability: Global export-ready with robust packaging and cold-chain considerations where required
• Price Competitiveness: Optimized manufacturing processes enabling cost-effective sourcing without compromising quality
• Sustainability: Environmentally responsible production practices aligned with international compliance standards
• Technical Support: Comprehensive documentation including COA, MSDS, DMF support, and regulatory filing assistance

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity: ~12–15 MT per 20-ft container (depending on packaging configuration)